0E44
Multi Units Luxembourg - Lyxor EuroMTS 7-10Y Investment Grade (0E44)
Market Closed
28 Mar, 15:30
LSE 
€
165. 10
+0.41
+0.25%
€
- Market Cap
- P/E Ratio
0% Div Yield
10 Volume
- Eps
€ 164.69
Previous Close Day Range
165.1 165.1
Year Range
159.79 186.83
Summary
0E44 closed Friday higher at €165.1, an increase of 0.25% from Thursday's close, completing a monthly decrease of -1.39% or €2.33. Over the past 12 months, 0E44 stock lost -1.11%.
0E44 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on XETRA (EUR).
Want to track 0E44 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0E44 Chart
Loading, please wait...
Multi Units Luxembourg - Lyxor EuroMTS 7-10Y Investment Grade Dividends
0E44 is not paying dividends to its shareholders.
Multi Units Luxembourg - Lyxor EuroMTS 7-10Y Investment Grade Earnings
0E44 have yet to publish their earning reports.
0E44 is not paying dividends to its shareholders.
0E44 have yet to publish their earning reports.
Multi Units Luxembourg - Lyxor EuroMTS 7-10Y Investment Grade (0E44) FAQ
What is the stock price today?
The current price is €165.10.
On which exchange is it traded?
Multi Units Luxembourg - Lyxor EuroMTS 7-10Y Investment Grade is listed on XETRA.
What is its stock symbol?
The ticker symbol is 0E44.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Multi Units Luxembourg - Lyxor EuroMTS 7-10Y Investment Grade ever had a stock split?
No, there has never been a stock split.
Multi Units Luxembourg - Lyxor EuroMTS 7-10Y Investment Grade Profile
| - Industry | - Sector | - CEO | LSE Exchange | LU1287023185 ISIN |
| Taiwan Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Contact Information
Address: -
Phone: (02)2700-8399
2025 © Marketlog. All Rights Reserved.
